Clinical Trial Update: Calcitonin Pre-treatment to Improve SPECT-CT Sensitivity [Phase 4]

View source ↗

Summary

Phase 4 trial update examining calcitonin pretreatment to improve SPECT-CT sensitivity in patients with primary hyperparathyroidism and hypercalcemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercalcemia
• Hyperparathyroidism

Drugs mentioned

• Calcitonin (calcitonin)

Snippet

Sponsor: Joseph Sferra | Conditions: Primary Hyperparathyroidism, Hypercalcemia | Phase 4 | Status: RECRUITING